TILT-123

tilt-123 · TILT Biotherapeutics Ltd.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for TILT-123, covering 2025-08-07 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: TNFα and IL-2 Coding Oncolytic Adenovirus TILT-123 Monotherapy [Phase 1]